Two new graphics from Diabetes UK's COVID-19 task force address inpatient use of subcutaneous insulin for managing hyperglycemia and ketoacidosis when intravenous equipment is unavailable.
from WebMD Health https://ift.tt/3deJTZw
Two new graphics from Diabetes UK's COVID-19 task force address inpatient use of subcutaneous insulin for managing hyperglycemia and ketoacidosis when intravenous equipment is unavailable.
A roundup of the latest news about COVID-19
Between the first seven days of January 2020 and the last seven days of March, mean daily controller inhaler use rose 14.5%.
Here are some of the top trending COVID-19 topics dominating the social media conversation among clinicians.
The COVID-19 pandemic has done untold economic damage in the United States, and the healthcare system is no exception.